These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1891899)

  • 1. [Changes in the lungs in progressive systemic scleroderma].
    Georgiev O; Marinov Kh; Rashkov R; Shoshkov P
    Vutr Boles; 1991; 30(2):51-5. PubMed ID: 1891899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Longitudinal study of parameters of respiratory function tests and blood gas analysis in patients with progressive systemic scleroderma].
    Georgiev O; Shoshkov P; Rashkov R
    Vutr Boles; 2001; 33(2-3):37-40. PubMed ID: 12001574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary function in patients with systemic sclerosis.
    Spagnolatti L; Zoia MC; Volpini E; Convertino G; Fulgoni P; Corsico A; Vitulo P; Cerveri I
    Monaldi Arch Chest Dis; 1997 Feb; 52(1):4-8. PubMed ID: 9151512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Functional cardio-respiratory aspects of scleroderma].
    Morpurgo M; Rampulla C; Beulcke G; Casaccia M; Finardi G; Venco A
    Schweiz Med Wochenschr; 1972 Apr; 102(17):605-11. PubMed ID: 5021874
    [No Abstract]   [Full Text] [Related]  

  • 5. Pulmonary involvement in progressive systemic sclerosis: a multidisciplinary approach.
    Pistelli R; Maini CL; Fuso L; Muzzolon R; Bonetti MG; Incalzi RA; Giordano A; Paoletti S
    Respiration; 1987; 51(4):296-306. PubMed ID: 3310160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive diagnostic and functional evaluation of cardiac and pulmonary involvement in systemic sclerosis.
    Sergiacomi G; De Nardo D; Capria A; Manenti G; Fabiano S; Borzi M; De Sanctis G; Konda D; Sperandio M; Schillaci O; Masala S; Simonetti G; Fontana L
    In Vivo; 2004; 18(2):229-35. PubMed ID: 15113051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung disease associated with progressive systemic sclerosis. Assessment of interlobar variation by bronchoalveolar lavage and comparison with noninvasive evaluation of disease activity.
    Miller KS; Smith EA; Kinsella M; Schabel SI; Silver RM
    Am Rev Respir Dis; 1990 Feb; 141(2):301-6. PubMed ID: 2301848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pulmonary changes in progressive systemic sclerosis].
    Yao WZ
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Jun; 13(3):157-9, 191. PubMed ID: 2249319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical features of systemic scleroderma with lesions in respiratory organs].
    Petrova DV; Shoĭkhet IaN; Berestov SA; Dorokhov AE
    Klin Med (Mosk); 2013; 91(6):30-4. PubMed ID: 24417064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Respiratory function profile in scleroderma. 20 cases (author's transl)].
    Kleisbauer JP; Feliciano JM; Colonna J; Velardocchio JM; Laval P
    Poumon Coeur; 1980; 36(6):371-6. PubMed ID: 7220421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diffusion disorders in patients with scleroderma].
    Konietzko N; Carton RW
    Beitr Klin Erforsch Tuberk Lungenkr; 1969; 139(3):196-205. PubMed ID: 5801289
    [No Abstract]   [Full Text] [Related]  

  • 12. Mast cells' contribution to the fibrosing alveolitis of the scleroderma lung.
    Chanez P; Lacoste JY; Guillot B; Giron J; Barnéon G; Enander I; Godard P; Michel FB; Bousquet J
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1497-502. PubMed ID: 8503561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical aspects of respiratory pathology in scleroderma. Case reports].
    Galietti F; Giorgis GE; Ardizzi A; Oliaro A; Zampollo M; Bernardi V; Miravalle C
    Minerva Med; 1990 Mar; 81(3):181-4. PubMed ID: 2320285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung impairment in scleroderma.
    Piorunek T; Kuznar-Kaminska B; Cofta S; Batura-Gabryel H; Poplawski D; Majewski D; Puszczewicz M; Wysocka E
    Adv Exp Med Biol; 2013; 755():149-54. PubMed ID: 22826062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis.
    Clements PJ; Roth MD; Elashoff R; Tashkin DP; Goldin J; Silver RM; Sterz M; Seibold JR; Schraufnagel D; Simms RW; Bolster M; Wise RA; Steen V; Mayes MD; Connelly K; Metersky M; Furst DE;
    Ann Rheum Dis; 2007 Dec; 66(12):1641-7. PubMed ID: 17485423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the functional parameters in scleroderma cases with pulmonary involvement.
    Celebi Sözener Z; Karabıyıkoğlu G; Düzgün N
    Tuberk Toraks; 2010; 58(3):235-41. PubMed ID: 21038133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pulmonary changes in diffuse scleroderma in the radiologic and pneumonologic picture].
    Dolinský A
    Vnitr Lek; 1979 Nov; 25(11):1127-30. PubMed ID: 516494
    [No Abstract]   [Full Text] [Related]  

  • 18. Lung function in progressive systemic sclerosis is dominated by poorly compliant lungs and stiff airways.
    Blom-Bülow B; Jonson B; Brauer K
    Eur J Respir Dis; 1985 Jan; 66(1):1-8. PubMed ID: 3979473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessments of pulmonary involvement in patients with systemic sclerosis.
    Gohari Moghadam K; Gharibdoost F; Parastandechehr G; Salehian P
    Arch Iran Med; 2011 Jan; 14(1):22-6. PubMed ID: 21194257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary manifestations of progressive systemic sclerosis.
    DeMuth GR; Furstenberg NA; Dabich L; Zarafonetis CJ
    Am J Med Sci; 1968 Feb; 255():94-104. PubMed ID: 5639554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.